| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
46,882 |
40,069 |
$5.62M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,536 |
23,789 |
$1.11M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,424 |
5,361 |
$403K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,199 |
4,136 |
$325K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,056 |
2,991 |
$230K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,185 |
2,111 |
$165K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,793 |
2,655 |
$92K |
| 99381 |
|
790 |
756 |
$69K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,835 |
5,597 |
$53K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,830 |
1,743 |
$46K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
780 |
758 |
$41K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,171 |
7,015 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,078 |
1,486 |
$28K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
407 |
389 |
$7K |
| 97803 |
|
641 |
618 |
$6K |
| 87807 |
|
609 |
583 |
$4K |
| 97802 |
|
325 |
317 |
$2K |
| 92552 |
|
3,474 |
3,377 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$704.75 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
75 |
64 |
$607.07 |
| 90619 |
|
22 |
22 |
$423.39 |
| 99000 |
|
18 |
18 |
$118.80 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
849 |
828 |
$24.24 |
| 96160 |
|
119 |
111 |
$18.24 |
| 90461 |
|
366 |
359 |
$1.78 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,795 |
8,646 |
$1.69 |
| 90620 |
|
298 |
282 |
$1.60 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,342 |
6,229 |
$0.40 |
| 90474 |
|
2,250 |
2,215 |
$0.09 |
| 90686 |
|
2,144 |
2,106 |
$0.01 |
| 90696 |
|
660 |
646 |
$0.00 |
| 90680 |
|
2,513 |
2,474 |
$0.00 |
| 90723 |
|
2,496 |
2,463 |
$0.00 |
| 3351F |
|
75 |
74 |
$0.00 |
| 90677 |
|
957 |
945 |
$0.00 |
| 90647 |
|
2,531 |
2,504 |
$0.00 |
| 2010F |
|
5,713 |
5,036 |
$0.00 |
| 90688 |
|
40 |
39 |
$0.00 |
| 2001F |
|
749 |
680 |
$0.00 |
| 90651 |
|
717 |
704 |
$0.00 |
| 90698 |
|
43 |
43 |
$0.00 |
| 3008F |
|
3,949 |
3,687 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
183 |
174 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| 4140F |
|
16 |
16 |
$0.00 |
| 96127 |
|
102 |
101 |
$0.00 |
| 2000F |
|
3,038 |
2,772 |
$0.00 |
| 3074F |
|
199 |
193 |
$0.00 |
| 36416 |
|
185 |
180 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
64 |
62 |
$0.00 |
| 90697 |
|
30 |
30 |
$0.00 |
| 85018 |
|
37 |
37 |
$0.00 |
| 90710 |
|
1,856 |
1,822 |
$0.00 |
| 90715 |
|
482 |
471 |
$0.00 |
| 90734 |
|
859 |
831 |
$0.00 |
| 3210F |
|
469 |
458 |
$0.00 |
| 90633 |
|
2,034 |
1,999 |
$0.00 |
| 90670 |
|
2,818 |
2,785 |
$0.00 |
| 4120F |
|
6,633 |
6,375 |
$0.00 |
| 90700 |
|
863 |
855 |
$0.00 |
| 3078F |
|
183 |
177 |
$0.00 |
| 4124F |
|
2,491 |
2,406 |
$0.00 |
| 99173 |
|
3,777 |
3,661 |
$0.00 |
| 3028F |
|
554 |
525 |
$0.00 |
| 1039F |
|
13 |
13 |
$0.00 |
| 1159F |
|
286 |
272 |
$0.00 |
| 90648 |
|
36 |
36 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
14 |
14 |
$0.00 |
| 4025F |
|
19 |
18 |
$0.00 |